美国头癌患者接种流感疫苗的模式
Maxwell Y Lee1, John B Sunwoo1, Michelle M Chen1
1Department of Otolaryngology - Head and Neck Surgery Stanford University School of Medicine Palo Alto California USA.
Laryngoscope investigative otolaryngology
|February 23, 2026
概括
尽管有建议,但头癌患者的流感疫苗接种率很低. 需要有针对性的干预措施来改善这种高风险群体的疫苗接种和预防护理.
科学领域:
- 在瘤学瘤学.
- 预防传染病 预防传染病
- 公共卫生 公共卫生
背景情况:
- 美国临床瘤学会建议癌症患者进行常规流感疫苗接种.
- 缺乏疫苗接种可以增加感染风险,严重程度,并延迟癌症治疗.
- 在头癌患者中接种流感疫苗的情况没有得到充分的记录.
研究的目的:
- 为了确定头癌患者中流感疫苗接种率.
- 为了确定与这一群体接种疫苗相关的因素.
主要方法:
- 追溯的队列分析.
- 使用了SEER-Medicare数据库.
- 包括65岁及以上的患者,在2013年至2018年期间被诊断患有头癌.
主要成果:
- 在32,155名患者中,32.5%的患者在诊断前接种了疫苗,32.1%的患者在诊断后接种了疫苗.
- 疫苗接种率在诊断时增加,但在3个月内下降.
- 较低的疫苗接种率与黑人和AAPI种族/种族,男性性别和晚期癌症转移有关.
结论:
- 在头癌患者中,流感疫苗接种率低于最佳水平.
- 有针对性的干预措施是必要的,以改善预防性护理和患者的结果.
- 解决疫苗接种方面的差异对于高风险癌症人群至关重要.
相关概念视频
Cancer Vaccines
1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
Vaccinations
52.2K
Overview
52.2K


